←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Trials, Dose Escalation Design
Peter F. Thall
PhD
🏢MD Anderson Cancer Center🌐USA
Professor of Biostatistics
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Peter Thall is a leading biostatistician in Bayesian adaptive trial design with major contributions to phase I/II methodology including the EffTox design. His work has provided utility-based frameworks that jointly model efficacy and toxicity. He is widely recognized for innovative early phase trial methods.
Share:
🧪Research Fields 研究领域
Bayesian adaptive design
phase I/II trials
dose finding
biostatistics
utility based design
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Peter F. Thall 的研究动态
Follow Peter F. Thall's research updates
留下邮箱，当我们发布与 Peter F. Thall（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment